Slim Weight Loss Clinic

Slim Weight Loss Clinic in Wilmington, NC, operates under the medical direction of Dr. Gary T. Marshall, MD, FACS, a board-certified surgeon who applies surgical precision to non-surgical weight management protocols. The clinic focuses exclusively on medically supervised weight loss using GLP-1 receptor agonist peptide therapies, providing patients throughout North Carolina with access to prescription medications that address the hormonal and metabolic factors underlying obesity. Dr. Marshall's background as a Fellow of the American College of Surgeons informs his approach to patient evaluation, ensuring that each weight loss plan accounts for individual metabolic profiles, comorbid conditions, and realistic goal-setting based on clinical evidence rather than marketing promises.

The clinic's peptide therapy program centers on three FDA-approved GLP-1 receptor agonists: Liraglutide, Semaglutide, and Tirzepatide. Liraglutide is typically prescribed as a daily subcutaneous injection for patients requiring gradual appetite regulation and glycemic control, particularly those with type 2 diabetes as a comorbidity. Semaglutide, available in weekly injection form, offers enhanced weight loss outcomes through prolonged GLP-1 receptor activation and is often selected for patients seeking less frequent dosing schedules. Tirzepatide represents the clinic's dual-agonist option, targeting both GLP-1 and GIP receptors to produce more pronounced effects on satiety, insulin sensitivity, and body composition changes. Dr. Marshall determines peptide selection based on patient-specific factors including baseline hemoglobin A1c levels, cardiovascular risk profiles, gastrointestinal tolerance, and weight loss velocity targets established during the initial consultation.

Dr. Marshall conducts comprehensive metabolic assessments before initiating peptide therapy, reviewing patient histories for contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastroparesis. His surgical background enables him to identify patients who may benefit from peptide therapy as a bridge to bariatric surgery or as a standalone intervention for those who are not surgical candidates. The clinic's protocol includes baseline laboratory work to establish thyroid function, kidney function, and lipid panels, with follow-up testing scheduled at regular intervals to monitor treatment response and adjust dosing protocols. Patients receive detailed instruction on subcutaneous injection technique, proper medication storage, and recognition of adverse effects requiring medical attention, such as persistent nausea, pancreatitis symptoms, or hypoglycemia in patients using concurrent diabetes medications.

Slim Weight Loss Clinic delivers all consultations and follow-up appointments via HIPAA-compliant telehealth platforms, eliminating geographic barriers for patients across Wilmington and surrounding coastal North Carolina communities. Initial consultations typically last 45 to 60 minutes and include review of medical records, discussion of previous weight loss attempts, assessment of eating patterns and physical activity levels, and explanation of how GLP-1 receptor agonists alter appetite signaling and gastric emptying. Dr. Marshall provides realistic timelines for weight loss, typically projecting 1 to 2 pounds per week during active treatment phases, and discusses the importance of dietary modifications and behavioral changes that support long-term weight maintenance after peptide therapy concludes. Follow-up appointments occur monthly during dose titration phases and quarterly once patients reach therapeutic dosing, with adjustments made based on weight loss velocity, side effect profiles, and patient-reported quality of life measures.

The clinic's telehealth model allows Dr. Marshall to prescribe peptide medications to patients throughout North Carolina, with prescriptions sent directly to patients' preferred pharmacies for local pickup or mail-order delivery through specialty pharmacies experienced in handling temperature-sensitive peptide formulations. This access model proves particularly valuable for patients in rural areas surrounding Wilmington who previously lacked local access to physician-supervised GLP-1 therapy. Slim Weight Loss Clinic does not accept insurance for weight management services, operating on a self-pay basis that includes consultation fees separate from medication costs, which vary based on peptide selection, dosing requirements, and pharmacy pricing. Dr. Marshall's practice emphasizes that peptide therapy represents one component of comprehensive obesity treatment, recommending concurrent nutritional counseling and exercise programming through patients' local resources to maximize metabolic outcomes and minimize weight regain after treatment completion.